-
Article
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework
-
Article
Chronic cardiovascular–kidney disorder: a new conceptual framework
The current nomenclature for cardiorenal syndrome is problematic owing to its chronological approach and the systemic nature of some of the subtypes. We suggest adoption of a new concept, chronic cardiovascula...
-
Article
New insights into epidemiological data and impact of the COVID-19 pandemic on IgA vasculitis in children and adults: a French nationwide cohort
IgA vasculitis (IgAV) is a small size vasculitis for which epidemiologic data are strikingly lacking, especially about the adult form. Additionally, the COVID-19 pandemic seems to have profoundly modified the ...
-
Article
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
The immune form of thrombotic thrombocytopenic purpura (iTTP) and the hemolytic and uremic syndrome (HUS) are two major forms of thrombotic microangiopathy (TMA). Their treatment has been recently greatly impr...
-
Article
Open AccessThrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology
Thrombotic microangiopathies (TMAs) are rare but can be severe in kidney transplant.
-
Article
Blood pressure management and long-term outcomes in kidney transplantation: a holistic view over a 35-year period
Hypertension is a burden for most kidney transplant recipients. Whether respect of hypertension guidelines results in better outcomes is unknown.
-
Article
Open AccessCombining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)
Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes ...
-
Article
Open AccessClinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry
Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) often caused by alternative complement dysregulation. Patients with aHUS can present with malignant hypertension (MH...
-
Article
Towards better indications for kidney biopsy in adult IgA vasculitis: a clinical-laboratory and pathology correlation study
Indications for kidney biopsy in adult IgA vasculitis (IgAV) remain debated and there are very few studies on this subject. The aim of this study was to establish a correlation between renal histological and c...
-
Article
Open AccessWhat is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study
The impact of blood pressure on neurological symptoms and risk of end-stage kidney disease (ESKD) is unknown in primary and secondary thrombotic microangiopathies (TMAs).
-
Article
Open AccessEarly changes in renal resistive index and mortality in diabetic and nondiabetic kidney transplant recipients: a cohort study
Renal resistive index (RI) predicts mortality in renal transplant recipients (RTR). However, its predictive value may be different according to the time of measurement. We analysed RI changes between 1 month a...
-
Article
Open AccessRenal arteriography with endovascular ultrasound for the management of renal infarction patients
Renal infarction (RI) is a rare disease with poor prognosis. Appropriate secondary prevention treatment is essential and requires an exhaustive etiological assessment. We aimed to determine whether invasive en...
-
Article
Open AccessClinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study
Infection-related glomerulonephritis with IgA deposits (IRGN-IgA) is a rare disease but it is increasingly reported in the literature. Data regarding epidemiology and outcome are lacking, especially in Europe....
-
Article
Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study
N-terminal pro-B-type natriuretic peptide (NT-proBNP) is the gold standard prognostic biomarker for diagnosis and occurrence of heart failure. Here, we compared its prognostic value for the occurrence of conge...
-
Article
Open AccessProceedings of Réanimation 2017, the French Intensive Care Society International Congress
-
Article
ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients
A high serum angiopoietin-like 2 (ANGPTL2) concentration is an independent risk factor for develo** diabetes and is associated with insulin resistance and atherosclerosis. In this work, we have examined the ...
-
Article
Open AccessBlood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: experience from the prospective observational ALICE-PROTECT study
Type 2 diabetes (T2DM) is the leading cause of chronic kidney disease (CKD) in western countries. The combination of both increases the risk of end stage renal disease (ESRD), cardiovascular events and all-cau...
-
Article
Community pharmacist intervention in patients with renal impairment
Background In France, community pharmacists do not have free access to patients’ lab results, and it is therefore impossible for them to identify patients with renal impairment. Objective
-
Article
Deficits in information transfer between hospital-based and primary-care physicians, the case of kidney disease: a cross-sectional study
Late recognition plays an important role in prognosis associated with kidney disease; thus, information transfer at hospital discharge regarding kidney disease is crucial. Whether it is notified in patients’ h...
-
Article
Open AccessImpact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
Patients are at risk of drug-related problems (DRPs) at transition points during hospitalization. The community pharmacist (CP) is often the first healthcare professional patients visit after discharge. CPs la...
